![Hans Christopher Toll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans Christopher Toll
Director of Finance/CFO at
KDVENTURES AB
Profile
Hans Christopher Toll currently works at Umecrine Cognition AB, as Chief Financial Officer from 2021 and KDventures AB, as Chief Financial Officer from 2022.
Mr. Toll also formerly worked at AIK Fotboll AB, as Chief Financial Officer and QUIA PHARMA AB, as Chief Financial Officer.
Mr. Toll received his Masters Business Admin degree from Stockholm School of Economics.
Hans Christopher Toll active positions
| Companies | Position | Start |
|---|---|---|
| KDVENTURES AB | Director of Finance/CFO | 2022-09-30 |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Director of Finance/CFO | 2020-12-31 |
Former positions of Hans Christopher Toll
| Companies | Position | End |
|---|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Director of Finance/CFO | - |
| AIK FOTBOLL AB | Director of Finance/CFO | - |
Training of Hans Christopher Toll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AIK Fotboll AB
 AIK Fotboll AB Movies/EntertainmentConsumer Services Engages in the management of football teams and activities | Consumer Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Quiapeg Pharmaceuticals Holding AB
 Quiapeg Pharmaceuticals Holding AB BiotechnologyHealth Technology Provides holdings in developing biopharmaceuticals for the treatment of metabolic disorders | Health Technology |
- Stock Market
- Insiders
- Hans Christopher Toll
